Reuters logo
BRIEF-Innate Pharma expands Phase I/II trial testing lirilumab with Opdivo
March 13, 2017 / 6:23 AM / 8 months ago

BRIEF-Innate Pharma expands Phase I/II trial testing lirilumab with Opdivo

March 13 (Reuters) - Innate Pharma SA:

* Announces the expansion of Phase I/II trial evaluating lirilumab in combination with Opdivo Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below